CD163 and adult T-cell leukemia/lymphoma: The role of TAM in ATLL showed in pre-clinical studies was confirmed and a significant correlation between CD163-positive TAM and poor prognosis was reported in 58 ATLL patients, in which double-immunostaining demonstrated CD163-positive TAM also expressed a CD68 marker [55].